Red blood cell-derived microparticles: An overview

Blood Cells, Molecules, and Diseases

Volumn 59, Issue , 2016, Pages 134-139

  Westerman, Maxwell ^a   Porter, John B ^b  

^a MOUNT SINAI HOSPITAL   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Overview; Red blood cell derived microparticles

Indexed keywords

CHLORPROMAZINE; NITRIC OXIDE; PHOSPHATIDYLSERINE; PRIMAQUINE; TETRACYCLINE;

BLOOD CLOTTING; BLOOD SAMPLING; CELL COMMUNICATION; ELLIPTOCYTOSIS; ERYTHROCYTE COUNT; ERYTHROCYTE MEMBRANE; ERYTHROCYTE MICROPARTICLE CLEARANCE; ERYTHROCYTE MICROPARTICLE COMPOSITION; ERYTHROCYTE MICROPARTICLE FORMATION; ERYTHROCYTE MICROPARTICLE STRUCTURE; ERYTHROCYTE PARAMETERS; FLOW CYTOMETRY; FLUORESCENCE GATING; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEREDITARY SPHEROCYTOSIS; HUMAN; MEMBRANE MICROPARTICLE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROCEDURES CONCERNING CELLS; RED BLOOD CELL DERIVED MICROPARTICLE; REVIEW; SICKLE CELL ANEMIA; SICKLE CELL TRAIT; SIZE GATING; STOMATOCYTOSIS; THALASSEMIA INTERMEDIA; CYTOLOGY; ERYTHROCYTE; HEMATOLOGIC DISEASE; PATHOLOGY;

CELL-DERIVED MICROPARTICLES; ERYTHROCYTES; HEMATOLOGIC DISEASES; HUMANS;

EID: 84969940476     PISSN: 10799796     EISSN: 10960961     Source Type: Journal    
DOI: 10.1016/j.bcmd.2016.04.003     Document Type: Review

References (75)

1. Auer J. The structure and function of filaments produced by living red corpuscles. Am. J. Med. Sci. 1933, 186:776-794.
2. Kite G.L. Some structural transformations of the blood-cells of vertebrates. J. Infect. Dis. 1914, 15:319.
3. Waitz R. Le phenomene d'expulsion de substances hors des hematies (hematexodies). Son etude experimentale. Ann. Med. 1936, 40:413.
4. Bessis M., Mandon P. La microspherulation et les forms myelinques des globules rouges. Nouv. Rev. Fr. Hematol. 1972, 12:443-454.2.
5. Jensen W.N., Bromberg P.A., Bessis M.C. Microincision of sickled erythrocytes by a laser beam. Science 1967, 155:704-708.
6. Padilla F., Bromberg P.A., Jensen W.N. The sickle-unsickle cycle: a cause of cell fragmentation leading to permanently deformed cells. Blood 1973, 41:653-660.
7. Allan D., Michell R.H. Accumulation of 1.2-diaclglycerol in the plasma membrane may lead to echinocyte transformation of erythrocytes. Nature 1975, 27:348-349.
8. Allan D., Michell R.H. Elevation of intracellular calcium ion concentration provokes production of1,2-diacylglycerol and phosphatidate in human erythrocytes. Biochem. Soc. Trans. 1975, 3. (151-2.7).
9. 2+]. Nature 1976, 261:58-608.
10. Lutz H.U., Liu S.C., Palek J. Release of spectrin-free vesicles from human erythrocytes during ATP depletion 1. Characterization of spectrin-free vesicles. J. Cell Biol. 1977, 73:548-560.
11. Morel O., Morel N., Jessil L., et al. Microparticles: a critical component in the nexus between inflammation, immunity, and thrombosis. Semin. Immunopathol. 2011, 73:469-486.
12. Fressinet J.M., Toti F., Hugel B., et al. Apoptosis in vascular disease. Thromb. Haemost. 1999, 82:727-735.
13. Myaki Y., Nomura S., Myaki T., et al. High sheer stress can initiate both platelet aggregation and shedding of procoagulant microparticles. Blood 1999, 88:3456-3464.
14. Bosnan Giel J.C.G.M., Lasonder E., Groenen-Dopp Y.A.M., et al. The proteome of erythrocyte-derived microparticles from plasma: new clues for erythrocyte aging and vesiculation. J. Proteome 2012, 76:203-210.
15. Salzer U., Hinterdorfer P., Hunger U., et al. Ca(++)-dependent vesicle release from erythrocytes involves stomatin-specific lipid rafts, synexin (annexin VII), and sorcin. Blood 2002, 99:2569-2577.
16. Wagner G.M., Chiu D.T.-Y., Yee M.C., et al. Red cell vesiculation - a common membrane event. J. Lab. Clin. Med. 1986, 103:316-324.
17. Wagner G.M., Schwartz R.S., Chiu D., et al. Membrane phospholipid organization and vesiculation of erythrocytes in sickle cell anemia. Clin. Haematol. 1985, 14:183-200.
18. Arraud N., Linares R., Tan S., et al. Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype, and concentration. J. Thromb. Haemost. 2014, 12:614-627.
19. Were J.M., Willikens F.L., Bosch F.H., et al. The red cell revisited - matters of life and death. Cell. Mol. Biol. (Noisy-le-Grand) 2004, 50:139-145.
20. Willekins F.A., Werre J.M., Gronen-Dopp Y.A.M., et al. Erythrocyte vesiculation: a self-protective mechanism?. Br. J. Haematol. 2008, 141:549-556.
21. Zwall R.F.A., Schroit A.J. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 1997, 15:1121-1132.
22. Larson M.C., Woodlift J.E., Hillery C.A., et al. Phosphatidylethanolamine is externalized at the surface of microparticles. Biochim. Biophys. Acta 2012, 1821:1501-1507.
23. Stoeckenius W. An electron microscopic study of myelin figures. J. Biophys. Biochem. Cytol. 1959, 5:491-500.
24. Stockenius W. Structure of the plasma membrane. Circulation 1962, 26:1066-1069.
25. Stoeckenius W., Schulman J.H., Prince L.M. The structure of myelin figures and microemulsions as observed with the electron microscope. Colloid Polym. Sci. 1960, 69(1):170-180.
26. Willekins F.L., Were J.M., Kruijt E., et al. Liver Kufpffer cells rapidly remove red blood cell-derived vesicles from the circulation by scavenger recepters. Blood 2005, 1:2141-2145.
27. van den Goor J.M., Nieuwland R., van Oeveren W., et al. Cell saver device. Cardiovasc. Surg. 2007, 134:798-799.
28. van der Meijden P.E.J., van Schilfgaarde M., van Oerle R., et al. Platelet- and 8 circulate in healthy humans and support low grade thrombin generation. Thromb. Haemost. 2001, 85:639-646.
29. Biro E., Sturk-Maquelin K.N., Vogel G.M., et al. Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. J. Thromb. Haemost. 2003, 1:2561-2568.
30. KoshIar R.L., Somajo S., Norstrom E., et al. Erythrocyte-derived microparticles supporting activated protein C-mediated regulation of blood coagulation. PLoS One 2014, 19.
31. Wenche J., Johnson M.E., Bidot J., et al. Red cell-derived microparticles (RMP) as a haemostatic agent. Thromb. Haemost. 2013, 110:751-760.
32. Berkmans R.J., Nieuwland R., Boing A.N., et al. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb. Haemost. 2001, 85:639-646.
33. Forest A., Paulas E., Ray P., et al. Circulating microparticles and procoagulant activity in elderly patients. J. Gerontol. A Biol. Sci. Med. Sci. 2010, 65:414-420.
34. Ankarklev J., Hjelmqvist D., Mantel P.-Y. Uncovering the role of erythrocyte-derived extra cellular vesicles in malaria: from immune regulation to cell communication. J. Circ. 2014, 3:1-11.
35. Sloand E.M., Mainwaring k., Chen J., et al. Transfer of glycosylphosphatidylinositol-anchored proteins to deficient cells after transfusion in paroxysmal nocturnal hemoglobinuria. Blood 2004, 1:3782-3788.
36. Liu R., Klich I., Rataiczak J., et al. Erythrocyte-derived microvesicles may transfer phosphatidylserine to the surface of nucleated cells and falsely 'mark' them as apoptotic. Eur. J. Haematol. 2009, 83:220-229.
37. Mooberry M.J., Key N.S. Microparticle analysis in disorders of hemostasis and thrombosis. Cytometry A 2016, 89:111-122.
38. Snyder L.M., Fairbanks G., Trainor J., et al. Properties and characterization of vesicles released by young and old human red cells. Br. J. Haematol. 1985, 59:513-522.
39. Butikofer P., Brodbeck U., Ott P. Modulation of erythrocyte vesiculation by amphiphilic drugs. Biochim. Biophys. Acta 1987, 901:291-295.
40. Butikofer P., Lin Z.W., Kuypers F.A., et al. Chlorpromazine inhibits vesiculation, alter phosphoinositide turnover and changes deformability of ATP-depleted RBCs. Blood 1989, 73:1699-1704.
41. Bevers E.M., Wiedmer T., Comfurius P., et al. Defective Ca(2+)-induced microvesiculation and deficient expression of procoagulant activity in erythrocytes from a patient with a bleeding disorder: a study of the red blood cells of Scott syndrome. Blood 1992, 79:380-388.
42. Toti F., Satta N., Fressinaud E., et al. Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylcholine and hemorrhagic complications, is an inherited disorder. Blood 1996, 87:1409-1415.
43. Iglic A., Hagerstrand H., Kralj-Iglic, et al. A possible physical mechanism of red blood cell vesiculation obtained by incubation at high pH. J. Biomech. 1998, 31:151-156.
44. Bobrowska-Hagerstrand M., Hagerstrand H., Iglic A. Membrane skeleton and red blood cell vesiculation at low pH. Biochim. Biophys. Acta 1998, 1371:123-128.
45. Moore T., Sorokluva O., Pustovyy O., et al. Microscopic evaluation of vesicles shed by erythrocytes at elevated temperatures. Microsc. Res. Tech. 2013, 76:1163-1170.
46. Alaarg A., Schiffelers R.M., van Soinge W.W., et al. Red blood cell vesiculation in hereditary hemolytic anemia. Front. Physiol. 2013, 4:365.
47. Allan D., Limbrick A.R., Thomas P., et al. Release of spectrin-free spicules on reoxygenation of sickled erythrocytes. Nature 1982, 295:612-613.
48. Franck P.F.H., Bevers E.M., Lubin B.H., et al. Uncoupling of the membrane skeleton from the lipid bilayer. The cause of accelerated phospholipid flip-flop leading to an enhanced procoagulant activity of sickled cells. J. Clin. Invest. 1985, 75:183-190.
49. Liu S.C., Derick L.H., Zhai S., et al. Uncoupling of the spectrin based skeleton from the lipid bilayer in sickled red cells. Science 1991, 252:574-576.
50. Allan D., Low M.G., Finean J.B., et al. Changes in lipid metabolism and cell morphology following attack by phospholipase C (Clostridium perfringens) on red cells or lymphocytes. Biochim. Biophys. Acta 1975, 413:309-316.
51. 2+ accumulation and loss by aberrant endocytic vesicles in sickle erythrocytes. J. Cell. Physiol. 1992, 152:1-9.
52. Mankelow T.J., Griffins R.E., Trompeter S., et al. Autophagic vesicles on mature human reticulocytes explain phosphatidylserine-positive red cells in sickle cell disease. Blood 2015, 126:1831-1834.
53. Westerman M.P., Unger L., Kucuk O., et al. Phase changes in in membrane lipids in sickle red cell shed vesicles and sickle red cells. Am. J. Hematol. 1998, 58:177-182.
54. Liu C., Zhso W., Christ G.J., et al. Nitric oxide scavenging by red cell microparticles. Free Radic. Biol. Med. 2013, 65:1164-1173.
55. Allan D., Limbrick A.R., Thomas P., et al. Micro vesicles from sickle erythrocytes and their relation to irreversible sickling. Br. J. Haematol. 1981, 47. (383-350).
56. Camus S.M., Moraes D., Bonnin P., et al. Circulating cell membrane microparticles transfer heme to endothelial cells and trigger vasooclusions in sickle cell disease. Blood 2015, 125:3805-3814.
57. Gyorgy B., Modos K., Pallinger E., et al. Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters. Blood 2011, 117:e39-e48.
58. Westerman M.P., Cole E.R., WU K. The effect of spicules obtained from sickle red cells on clotting activity. Br. J. Haematol. 1984, 56:557-562.
59. van Beers E.J., Schap M.C.L., Berkmans R.B., et al. Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica 2009, 94:1513-1519.
60. Gerotziatas G.T., van Dreden P., Chiari M., et al. The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles. Thromb. Haemost. 2012, 107:1044-1052.
61. Westerman M.P., Pizzey A., Hirschman J., et al. Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis, and the effects of therapy. Br. J. Haematol. 2008, 142(1):126-135.
62. Mebor D., Romana M., Santiago R., et al. Fetal hemoglobin and hydroxycarbamide modulate both plasma concentration and cellular origin of circulating microparticles in sickle cell anemia in children. Haematologica 2012, 98:862-867.
63. Westerman M.P., Green D., Gilman-Sachs A., et al. Coagulation changes in individuals with sickle cell trait. Am. J. Hematol. 2002, 69:89-94.
64. Folsom A.R., Tara W., Roetker N.S., et al. Prospective study of sickle cell trait and venous thromboembolism. J. Thromb. Haemost. 2015, 13:2-9.
65. Lawrie A.S., Pizzey A., Trompeter S., et al. Procoagulant activity in patients with sickle cell trait. Blood Coagul. Fibrinolysis 2012, 23:268-270.
66. Harris K.M., Haas T.S., Eichner E.R., et al. Sickle cell trait associated with sudden death in competitive athletes. Am. J. Cardiol. 2012, 8:1185-1188.
67. Chaichompoo P., Kumya P., Khowawisetsut L., et al. Characterizations and proteome analysis of platelet-free plasma-derived microparticles in B-thalassemia/hemoglobin E patients. J. Proteome 2012, 5:239-250.
68. Fermi E., Pateleo A., Carla F., et al. Thalassemic erythrocytes release microparticles loaded with hemichromes by redox activation of p72Syk kinase. Haematologica 2014, 99:570-578.
69. Perrotta S., Gallagher P.G., Mohandas N. Hereditary spherocytosis. Lancet 2008, 9647:1411-1426.
70. Gallagher P. Hereditary elliptocytosis: spectrin and protein 4.1R Semin in hereditary hemolytic anemias. Front. Physiol. 2013, 4:1-15.
71. 2+ induced vesiculation in stomatin-deficient overhydrated hereditary stomatocytes. Biochim. Biophys. Acta 2008, 1778:125-132.
72. Snyder L.M., Lutz H.U., Souberman N., et al. Fragmentation and mylelin formation in hereditary xerocytosis and other hemolytic anemias. Blood 1978, 52:750-761.
73. Cappelini M., Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet 2008, 371:64-74.
74. Pantaleo A., Ferru E., Carta F., et al. Irreversible AE1 tyrosine phosphorelation leads to membrane vesiculation in G6PD deficient red cells. PLoS One 2011, 6:e15847.
75. Nantako D., Palasuwan A., Chaowanathikhom M., et al. Red cell and platelet-derived microparticles are increased in G6PD-deficient subjects. Eur. J. Haematol. 2012, 89:423-429.